Extracorporeal Life Support Organization (ELSO): Guidelines for Pediatric Cardiac Failure

Georgia Brown; Katie M Moynihan; Kristopher B Deatrick; Aparna Hoskote; Hitesh S Sandhu; Devon Aganga; Shriprasad R Deshpande; Anuradha P Menon; Thomas Rozen; Lakshmi Raman; Peta M A Alexander

doi:10.1097/MAT.0000000000001431

Extracorporeal Life Support Organization (ELSO): Guidelines for Pediatric Cardiac Failure

ASAIO J. 2021 May 1;67(5):463-475. doi: 10.1097/MAT.0000000000001431.

Authors

Georgia Brown¹, Katie M Moynihan^{2

3}, Kristopher B Deatrick⁴, Aparna Hoskote⁵, Hitesh S Sandhu⁶, Devon Aganga^{7

8}, Shriprasad R Deshpande⁹, Anuradha P Menon¹⁰, Thomas Rozen¹, Lakshmi Raman¹¹, Peta M A Alexander^{2

3}

Affiliations

¹ From the Cardiac Intensive Care Unit, The Royal Children's Hospital, Melbourne, Australia.
² Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.
³ Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
⁴ Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
⁵ Cardiorespiratory and Critical Care Division, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
⁶ Department of Pediatrics, Critical Care Division, Le Bonheur Children's Hospital, University of Tennessee, Memphis, Tennessee.
⁷ Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
⁸ Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.
⁹ Pediatric Cardiology Division, Heart Transplant and Advanced Cardiac Therapies Program, Children's National Heart Institute, Washington, D.C.
¹⁰ Children's Intensive Care Unit, Department of Paediatric Subspecialties, KK Women's and Children's Hospital, Singapore.
¹¹ Department of Critical Care, University of Texas Southwestern Medical Center, Texas.

PMID: 33788796
DOI: 10.1097/MAT.0000000000001431

Abstract

These guidelines are applicable to neonates and children with cardiac failure as indication for extracorporeal life support. These guidelines address patient selection, management during extracorporeal membrane oxygenation, and pathways for weaning support or bridging to other therapies. Equally important issues, such as personnel, training, credentialing, resources, follow-up, reporting, and quality assurance, are addressed in other Extracorporeal Life Support Organization documents or are center-specific.

MeSH terms

Anticoagulants / therapeutic use
Carbon Dioxide / metabolism
Child
Device Removal
Extracorporeal Membrane Oxygenation*
Heart Failure / therapy*
Humans
Patient Selection
Practice Guidelines as Topic*
Ventilators, Mechanical

Substances

Anticoagulants
Carbon Dioxide